04 June 2021
Appointment of full-time Chief Financial and Operations Officer to strengthen operational leadership
MyHealthChecked Plc (AIM: MHC), the consumer home-testing healthcare company, announces the appointment of Gareth Davies as Chief Financial and Operations Officer, a full-time role that will involve day-to-day operational oversight of the business during a period of substantial growth. Gareth succeeds Maddy Kennedy, who joined the Company in October 2019 with a remit to drive the cost efficiencies successfully delivered in 2020. Maddy is leaving her part-time CFO post to pursue her CFO/NED portfolio following the Company relocation to Cardiff, and to facilitate the transition to the full-time operational role to meet expected growth demands. Gareth will take up the position of CFO/COO and joins the Board on 4 June 2021. Maddy Kennedy will step down from the Board at the same time, but will continue to provide Company Secretarial support services to the Company during a transition period.
Gareth, a Chartered Accountant, is a commercially astute and driven business leader with extensive experience gained in finance and operations leadership within high growth medical device businesses, most recently with Welcony Inc, a leader in neurotechnology, as Group Chief Finance & Operations Officer since 2017.
During his time at Welcony, Gareth was part of a leadership team that led the business through a period of significant revenue and profitability growth. Prior to Welcony Inc, Gareth was Finance Director & General Manager at Flexicare (Group) Limited for 11 years from 2006 to 2017.
Gareth has extensive experience within high growth medical device businesses, covering operational and manufacturing processes, organic business scale up and cross border M&A activity.
Penny McCormick, Chief Executive Officer of MyHealthChecked PLC, commented:
“Gareth is joining us at a dynamic transitionary period for MyHealthChecked Plc, and he brings healthcare sector expertise along with deep, proven experience across operations and finance. This includes M&A, and process driven infrastructural developments, both essential in underpinning our medium to long term growth. We welcome Gareth to our Board at this exciting time, and wish him every success as he transitions the role significantly in line with our business plan. In doing so, on behalf of the Board I’d like to thank Maddy for her loyalty to the Group and delivery of key financial projects over the past 20 months, with our full support and good wishes for her future endeavours.”
The following additional information is provided in accordance with paragraph (g) of Schedule Two to the AIM Rules for Companies:
David Gareth Lloyd Davies (44) is currently or has been a director of the following companies within the previous five years:
|Current directorships/partnerships||Past directorships/partnerships|
|None||The Magstim Company Limited |
Flexicare (Group) Limited
|Flexicare Medical Limited|
Mr Davies does not have any beneficial interest in the ordinary shares of the Company.
Save as set out above, no further information is required to be disclosed pursuant to Schedule Two paragraph (g) of the AIM Rules for Companies.
|Penny McCormick, Chief Executive Officer||via Walbrook PR|
|SPARK Advisory Partners Limited (NOMAD)||Tel: +44 (0)20 3368 3550|
|Oberon Capital Ltd (Broker)||Tel: +44 (0)203 179 5344|
|Mike Seabrook||[email protected]|
|Walbrook PR Ltd (Media & Investor Relations)||Tel: +44 (0)20 7933 8780 or [email protected]|
|Paul McManus / Alice Woodings||Mob: +44 (0) 7980 541 893 / +44 (0)7407 804 654|
About MyHealthChecked PLC (www.myhealthcheckedplc.com)
MyHealthChecked PLC, based in Cardiff, is an AIM-quoted pioneering UK healthcare company focused on a range of at-home healthcare and wellness tests. MyHealthChecked is the umbrella brand of a range of at-home DNA and RNA tests, now in development following the acquisition of The Genome Store in November 2020. The tests will be made available online and would be viable for over-the-counter purchase.
The MyHealthChecked portfolio has been identified as part of a change in mindset as customers become more familiar with the concept of accessible healthcare in the growing at home testing kit market, with a focus on accessibility at the right price, led by UK-based experts.